Related Experiment Video
Updated: Aug 19, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Effect of L-arginine-nitric oxide system on chemical-induced diabetes mellitus
Abstract:
Several in vitro studies have suggested that nitric oxide may be the mediator of cytokine-induced beta-cell destruction. On the other hand, in vivo studies have given conflicting results: some studies suggesting that nitric oxide synthase inhibitors do not suppress streptozotocin-induced diabetes in mice, while others revealed that nitric oxide synthase inhibitors can reduce the incidence of insulin-dependent diabetes mellitus in rats. The results of the present study indicate that alloxan-induced diabetes in the male Wistar rats can be abrogated to a large extent by prior and simultaneous administration of the precursor of nitric oxide, L-arginine, where as NG-monomethy-L-arginine (L-NMMA), a specific inhibitor of nitric oxide synthase, can completely block the beneficial action of L-arginine. Sodium nitroprusside, a nitric oxide donor, also showed significant inhibitory effect on the severity of diabetes induced by alloxan. Alloxan treatment reduced nitric oxide generation, whereas L-arginine and sodium nitroprusside, when given along with alloxan, enhanced nitric oxide production to control values. Induction of diabetes by alloxan in the experimental animals was associated with a marked elevation in plasma lactate, ketone body, and lipid peroxide levels with a simultaneous fall in plasma insulin and nitric oxide levels. Alloxan-induced diabetes also induced a fall in the levels of anti-oxidant enzymes such as superoxide dismutase, glutathione reductase, and total glutathione, and antioxidants: vitamin E and ceruloplasmin, and an increase in glutathione peroxidase and glutathione-S-transferase. All these biochemical abnormalities and antioxidant levels have improved to near normal levels in animals treated with insulin, L-arginine, and sodium nitroprusside. From the results of the present study, it is apparent that L-arginine and nitric oxide can prevent alloxan-induced beta-cell damage, and the development of diabetes, and restore the antioxidant status to near normal levels.
Insights
Nitric oxide precursor L-arginine and nitric oxide donor sodium nitroprusside protect against alloxan-induced diabetes in rats. Nitric oxide synthase inhibitor L-NMMA blocked this protective effect, indicating nitric oxide
Area of Science:
- Biochemistry
- Endocrinology
- Immunology
Background:
- In vitro studies suggest nitric oxide mediates cytokine-induced beta-cell destruction.
- In vivo studies on nitric oxide synthase inhibitors and diabetes yield conflicting results.
Purpose of the Study:
- To investigate the role of nitric oxide in alloxan-induced diabetes in male Wistar rats.
- To determine the effects of L-arginine, L-NMMA, and sodium nitroprusside on alloxan-induced diabetes.
Main Methods:
- Alloxan was used to induce diabetes in rats.
- Rats were treated with L-arginine (nitric oxide precursor), L-NMMA (nitric oxide synthase inhibitor), or sodium nitroprusside (nitric oxide donor).
- Biochemical parameters including plasma insulin, nitric oxide, lactate, ketone bodies, lipid peroxides, and antioxidant enzyme levels were measured.
Main Results:
- L-arginine and sodium nitroprusside administration abrogated alloxan-induced diabetes.
- L-NMMA blocked the protective effects of L-arginine.
- Alloxan-induced diabetes caused metabolic and oxidative stress, which were ameliorated by insulin, L-arginine, and sodium nitroprusside treatments.
Conclusions:
- L-arginine and nitric oxide play a protective role against alloxan-induced beta-cell damage and diabetes development.
- Nitric oxide can restore antioxidant status in experimental diabetes.
- These findings highlight the therapeutic potential of nitric oxide modulation in diabetes.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Dipeptidyl Peptidase 4 Inhibitors
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology

